.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Daiichi Sankyo
Chinese Patent Office
Johnson and Johnson
Covington
Moodys
Chubb
Mallinckrodt
Cantor Fitzgerald
Express Scripts

Generated: November 20, 2017

DrugPatentWatch Database Preview

Clorazepate dipotassium - Generic Drug Details

« Back to Dashboard

What are the generic sources for clorazepate dipotassium and what is the scope of clorazepate dipotassium freedom to operate?

Clorazepate dipotassium
is the generic ingredient in four branded drugs marketed by Quantum Pharmics, Recordati Rare, Mylan, Sun Pharm Inds Ltd, Aurolife Pharma Llc, Lederle, Purepac Pharm, Gd Searle Llc, Warner Chilcott, Am Therap, Taro Pharm, Dava Pharms Inc, Usl Pharma, Watson Labs, Able, and Alra, and is included in sixty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for clorazepate dipotassium. Nine suppliers are listed for this compound.

Pharmacology for clorazepate dipotassium

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine

Medical Subject Heading (MeSH) Categories for clorazepate dipotassium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
TABLET;ORAL072014-001Dec 15, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
CAPSULE;ORAL071522-001Sep 12, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Warner Chilcott
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
CAPSULE;ORAL071774-001Mar 1, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
TABLET;ORAL017105-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
CAPSULE;ORAL071550-001Sep 12, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Aurolife Pharma Llc
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
TABLET;ORAL072514-001May 11, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
TABLET;ORAL071854-001Feb 9, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
TABLET;ORAL076911-003Sep 29, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
CAPSULE;ORAL017105-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Warner Chilcott
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
TABLET;ORAL071829-001Mar 3, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: clorazepate dipotassium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Recordati Rare
TRANXENE
clorazepate dipotassium
CAPSULE;ORAL017105-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
TABLET;ORAL017105-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
TABLET;ORAL017105-007Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Recordati Rare
TRANXENE SD
clorazepate dipotassium
TABLET;ORAL017105-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Recordati Rare
TRANXENE SD
clorazepate dipotassium
TABLET;ORAL017105-005Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
TABLET;ORAL017105-008Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
CAPSULE;ORAL017105-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
CAPSULE;ORAL017105-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Medtronic
Healthtrust
Cantor Fitzgerald
Merck
US Department of Justice
Mallinckrodt
Chubb
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot